Legendary investor Warren Buffett’s strategy of being fearful when others are greedy and the reverse is highlighted in recent trading activity for CureVac NV (CVAC). On Tuesday, shares of CureVac fell into oversold territory, recording a Relative Strength Index (RSI) of 29.0 after trading as low as $4.775 per share. This contrasts with the S&P 500 ETF (SPY), which has an RSI of 47.6.
CureVac’s stock has a 52-week range with a low of $2.475 per share and a high of $5.72, marking its last trade at approximately $4.80.
